Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > An excellent interview this morning

<< Previous

Bullboard Posts

Next >>

Post by steadfaston Aug 11, 2021 10:26am

228 Views

Post# 33684453

An excellent interview this morning

Just finished watching Dr T present a very professional slide presentation. Fortunately, to-date SVA
is keeping ahead of competition, we just have to ensure we continue to keep many steps ahead.
Product potential for diabetes $100,000 to $200,000 per patient. Did not give time frame.
Great potential, just going to take time. The immune protection will be The Holy Grail.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing